News | February 20, 2015

Mevion S250 Becomes Canada’s First Approved Proton Therapy System

Treatment provides more precise alternative to conventional radiation therapy

Mevion, S250, proton therapy, Canada, radiation, Health Canada, cancer

February 20, 2015 — The Mevion S250 proton therapy system has become the first proton therapy system to receive a medical device license from Health Canada, the federal department responsible for public health, and is now approved to be installed at cancer facilities across the country.

Proton therapy targets cancer cells more precisely than traditional photon radiation treatment and results in less damage to surrounding healthy tissue and organs. Because of this, it is ideal for treating pediatric patients and adult patients with cancers in sensitive locations, such as near the brain, spine, heart, and lungs.

The Mevion S250 offers the same capabilities of significantly larger and more expensive proton therapy systems but with a much smaller footprint, improved reliability, more efficient patient access and dramatically lower capital and operational costs.

According to the Canadian Cancer Society, an estimated 97,700 men and 93,600 women were diagnosed with cancer in Canada in 2014. Of these new cases, many were types of cancer that are frequently treated with proton therapy, including lung cancer (13.9 percent of new cancer cases in men, 13.3 percent in women), cancer in the brain or central nervous system (1.7 percent of new cancer cases in men, 1.3 percent in women), prostate cancer (24.1 percent of new cancer cases in men) and breast cancer (26.1 percent of new cancer cases in women).

For more information: www.mevion.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init